2-naphthol has been researched along with thromboplastin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Buckman, BO; Chou, YL; Lentz, D; Liang, A; Light, DR; McCarrick, M; Mohan, R; Morrissey, MM; Shaw, KJ; Trinh, L | 1 |
Akhmedov, A; Breitenstein, A; Camici, GG; Elliott, PJ; Holy, EW; Lohmann, C; Lüscher, TF; Matter, CM; Spescha, R; Stein, S; Tanner, FC; Westphal, CH | 1 |
2 other study(ies) available for 2-naphthol and thromboplastin
Article | Year |
---|---|
Solid-phase synthesis of naphthylamidines as factor VIIa/tissue factor inhibitors.
Topics: Amidines; Binding Sites; Factor VIIa; Humans; Kinetics; Models, Molecular; Molecular Conformation; Naphthols; Structure-Activity Relationship; Thromboplastin | 2005 |
Sirt1 inhibition promotes in vivo arterial thrombosis and tissue factor expression in stimulated cells.
Topics: Animals; Benzamides; Binding Sites; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelial Cells; Enzyme Activators; Genes, Reporter; Histone Deacetylase Inhibitors; Humans; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitogen-Activated Protein Kinases; Naphthalenes; Naphthols; Promoter Regions, Genetic; Pyrones; Resveratrol; RNA Interference; RNA, Messenger; Sirtuin 1; Stilbenes; Thromboplastin; Thrombosis; Transcription Factor RelA; Transfection | 2011 |